SLC6A3 and Parkinson disease: In the clinical diagnosis of PD, 11C-CFT PET/CT imaging provides a new direction for the early diagnosis and treatment of the disease, and differences in the amount of DAT binding in different parts of the striatum in PD patients are a reliable and objective indicator for the early diagnosis of PD.